# Phenethylamine

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/phenethylamine
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** β-phenylethylamine, PEA, 2-phenylethylamine, phenylethylamine, benzylmethylamine, 1-amino-2-phenylethane, phenethamine

## Overview

Phenethylamine (PEA) is a naturally occurring trace monoamine alkaloid found endogenously in the human brain and in foods such as chocolate, acting primarily as a releaser of catecholamines including [dopamine](/ingredients/condition/mood) and norepinephrine. It functions as a trace amine-associated receptor 1 (TAAR1) agonist, though its rapid monoamine oxidase B (MAO-B) [metabolism](/ingredients/condition/weight-management) severely limits its pharmacological duration in vivo.

## Health Benefits

• No clinically proven health benefits - no human clinical trials identified in available research
• Potential [neurotransmitter activity](/ingredients/condition/cognitive) - acts as a trace amine but pharmacological actions listed as unknown
• Possible 5-HT2A receptor binding - DrugBank notes potential interaction but without clinical evidence
• May influence serine protease activity - suggested activity against PRSS1 substrates but not clinically validated
• High oral bioavailability predicted - computational models suggest bioavailability rating of 1 (high) based on chemical properties

## Mechanism of Action

Phenethylamine acts as an agonist at trace amine-associated receptor 1 (TAAR1), triggering the release of dopamine, norepinephrine, and [serotonin](/ingredients/condition/mood) from presynaptic nerve terminals. It is rapidly degraded by monoamine oxidase B (MAO-B) with a plasma half-life of approximately 5–10 minutes, which severely curtails central nervous system exposure after oral ingestion. DrugBank also notes potential binding activity at the 5-HT2A serotonin receptor, though the clinical significance of this interaction has not been established in controlled human studies.

## Clinical Summary

No published randomized controlled trials have evaluated phenethylamine supplementation for any health outcome in human populations, making definitive efficacy claims unsupported by current evidence. One small, older study (Fischer et al., 1968) observed elevated urinary PEA excretion in subjects experiencing heightened mood states, suggesting an endogenous correlative role rather than a therapeutic one. Animal model research has demonstrated [dopamine](/ingredients/condition/mood)rgic and noradrenergic activity, but these findings have not been translated into validated human clinical outcomes. The overall evidence base is preclinical and observational, and no regulatory body has approved PEA for any medical indication.

## Nutritional Profile

Phenethylamine (PEA) is a biogenic amine and trace amine compound, not a conventional nutrient, and therefore lacks a traditional macronutrient or micronutrient profile. Molecular formula: C8H11N, molecular weight: 121.18 g/mol. It is a low-molecular-weight monoamine alkaloid structurally analogous to amphetamine. Not a source of protein, carbohydrates, fats, fiber, vitamins, or minerals in any nutritionally meaningful quantity. As a bioactive compound, it occurs endogenously in the human brain at trace concentrations (approximately 0.1–1.0 µg/g brain tissue). Dietary sources include fermented foods, chocolate (cocoa contains approximately 0.1–0.7 µg/g), aged cheeses, and certain fermented beverages, though concentrations are low and variable. Oral bioavailability is considered poor due to rapid first-pass [metabolism](/ingredients/condition/weight-management) by monoamine oxidase B (MAO-B) in the gut and liver, resulting in a very short plasma half-life (estimated under 5–10 minutes in most individuals). Primary metabolite is phenylacetic acid, formed via MAO-B oxidative deamination. Co-administration with MAO inhibitors significantly extends its half-life and systemic activity. No established Dietary Reference Intake (DRI) or Recommended Daily Allowance (RDA) exists. Not classified as an essential nutrient.

## Dosage & Preparation

No clinically studied dosage ranges are reported for any forms of phenethylamine (extract, powder, or standardized), as human clinical trials are absent from available sources. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Phenethylamine may cause adverse effects including increased heart rate, elevated [blood pressure](/ingredients/condition/heart-health), headache, and anxiety, particularly at higher doses, due to its catecholamine-releasing properties. Co-administration with monoamine oxidase inhibitors (MAOIs) such as phenelzine or selegiline poses a serious interaction risk, as MAO-B inhibition dramatically extends PEA's half-life and can precipitate hypertensive crisis or [serotonin](/ingredients/condition/mood) syndrome. Individuals with cardiovascular disease, hypertension, bipolar disorder, or schizophrenia should avoid PEA supplementation given its stimulant-like and potentially psychoactive profile. Safety data during pregnancy and lactation are absent, and use is not recommended in these populations.

## Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for phenethylamine were identified in the available research sources. DrugBank notes unknown pharmacological actions with only potential binding targets suggested, and no PubMed PMIDs are available for phenethylamine-specific clinical studies.

## Historical & Cultural Context

No historical context or uses in traditional medicine systems are described in the available research sources. The compound's traditional applications, if any, are not documented.

## Synergistic Combinations

No synergistic ingredients identified in research

## Frequently Asked Questions

### What does phenethylamine actually do in the brain?

Phenethylamine activates trace amine-associated receptor 1 (TAAR1), which stimulates the release of dopamine and norepinephrine from presynaptic neurons, producing transient stimulant-like effects. It is, however, metabolized within minutes by monoamine oxidase B (MAO-B), so its central effects after oral supplementation are brief and highly variable depending on MAO-B activity in the individual.

### Is phenethylamine found in chocolate?

Yes, phenethylamine is present in cacao and dark chocolate, and has been popularly linked to the mood-elevating effects of chocolate consumption. However, dietary PEA is almost entirely metabolized in the gut and liver before reaching systemic circulation, meaning the trace amounts in chocolate are unlikely to produce measurable psychoactive effects in most people.

### Can you take phenethylamine with antidepressants?

Combining phenethylamine with monoamine oxidase inhibitors (MAOIs) such as phenelzine, tranylcypromine, or selegiline is potentially dangerous, as these drugs block MAO-B, allowing PEA to accumulate and potentially trigger hypertensive crisis or serotonin syndrome. Caution is also warranted with SSRIs and SNRIs due to additive serotonergic activity; consultation with a healthcare provider is essential before combining PEA with any antidepressant medication.

### What is the recommended dosage of phenethylamine supplement?

There is no clinically established or regulatory-approved dosage for phenethylamine supplementation, as no human dose-response trials have been conducted. Commercial supplements typically provide between 250 mg and 1,000 mg per serving, often combined with MAO-B inhibitors like hordenine to extend PEA's half-life, though this combination has not been evaluated for safety or efficacy in controlled studies.

### Does phenethylamine help with weight loss or energy?

Phenethylamine is structurally related to amphetamines and stimulates catecholamine release, which theoretically could increase metabolic rate and suppress appetite, but no human clinical trials have demonstrated measurable weight loss or sustained energy benefits from PEA supplementation. Its extremely short half-life of approximately 5–10 minutes in the body means any stimulant effects dissipate rapidly, making it an unreliable standalone agent for energy or weight management based on current evidence.

### Is there clinical evidence that phenethylamine supplements actually work?

Currently, there are no human clinical trials demonstrating that phenethylamine supplements provide measurable health benefits. While phenethylamine exists as a natural trace amine in the brain and acts on certain receptors, the supplement form lacks rigorous scientific validation for efficacy in humans. Most claims about phenethylamine's effects remain theoretical rather than evidence-based.

### Who should avoid taking phenethylamine supplements?

People taking monoamine oxidase inhibitors (MAOIs) should avoid phenethylamine, as it may interact with these medications and potentially cause dangerous elevations in blood pressure. Additionally, those with uncontrolled hypertension, heart conditions, or thyroid disorders should consult a healthcare provider before supplementing, as phenethylamine's cardiovascular effects in humans remain poorly characterized. Pregnant and nursing women should avoid phenethylamine due to insufficient safety data in these populations.

### What is the difference between phenethylamine from food sources versus supplements?

Phenethylamine occurs naturally in small amounts in foods like chocolate, cheese, and fermented products, but these dietary levels are typically very low and may not survive stomach acid digestion. Supplement forms provide concentrated doses intended to reach systemic circulation, but whether oral supplementation meaningfully increases brain phenethylamine levels remains unproven in humans. The bioavailability and metabolic fate of supplemental phenethylamine differs substantially from trace amounts found in food.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*